Additionally, plasma TFPI1 levels in patients with non-small cell lung cancer (NSCLC) and breast cancer were significantly lower in the VTE group than in the non-VTE group [11,53]. The gene discussed is TFPI; the disease is non-small cell lung carcinoma.